Common heart failure drug reduces risk of chemotherapy-induced heart damage in cancer patients

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using anthracyclines, according to preliminary late-breaking science presented today at the American Heart Association’s Scientific Sessions 2024.

BT-7480 by Bicycle Therapeutics for Ovarian Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 18, 2023

More mandatory evacuations lifted in Pearl fire in Larimer County – The Cannabist

Larimer County officials lifted more mandatory evacuations in the Pearl fire burning west of Red Feather Lakes on Wednesday. The 128-acre wildfire that sparked Monday

September 19, 2024

Big Health buys Limbix to add adolescent depression app to digital therapeutic portfolio

Dive Brief: Big Health has bought Limbix to add a treatment for adolescent depression to its portfolio of digital therapeutics. The app, SparkRx, uses self-guided,

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.